US cancer trials may go the way of the Oldsmobile

Nature Medicine

Volumn 16, Issue 6, 2010, Pages 632-

  Dilts, David ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER RESEARCH; CANCER SURVIVAL; DRUG INDUSTRY; FUNDING; GOVERNMENT; MEDICAL PRACTICE; NOTE; PRIORITY JOURNAL; UNITED STATES;

CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; UNITED STATES;

EID: 77953189389     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0610-632     Document Type: Note

References (7)

1. Dickson, M. & Gagnon, J.P., Nat. Rev. Drug Discov. 3, 417-429, (2004).
2. Adams, W. & Brock, J. The bigness complex. 52 (Stanford University Press. 2004).
3. Dilts D.M., Cheng, S., Crites, J., Sandler, A. & Doroshow, J. Clin. Cancer Res., doi:10.1158/1078-0432.ccr-10-1273, 2010.
4. Dilts, D.M. & Sandler, A.B. J. Clin. Oncol. 24, 4545-4552 (2006).
5. Operational Efficiency Working Group of the Clinical Trials and Translational Research Advisory Committee. Compressing the Timeline for Cancer Clinical Trial Activation. http://ccct.cancer.gov/files/OEWG-Report.pdf (2010).
6. Institute of Medicine. A National Cancer Clinical Trials System for the 21st Century. http://books.nap.edu/openbook.php?record-id=12879 (2010).
7. Glickman, S.W. et al. N. Engl. J. Med. 360, 816-823 (2009).